Joint Chiefs Chairman Gen. Martin Dempsey says the United States is not providing Syrian rebels what they would need to win the war against President Bashar al-Assad’s regime.
Dempsey’s remarks keep the chairman ““ a former division commander in the Iraq war ““ on familiar footing, as he leads top Pentagon generals skeptical of using direct U.S. military force to aid Syrian rebels or otherwise intervene militarily in Syria’s future because of the country’s anticipated long-term security needs after any initial conflict. Dempsey outlined specifically why he believes Syria’s rebels need far more than a rescue mission.
“They need the force they have now, which is trying to protect local villages and try to harass the regime and level the playing field. They need something that eventually will be able to hold ground. And they need a counterterror capability ““ all of which is responsive to Syrians,” Dempsey said Wednesday at the Atlantic Council, a NATO-oriented think tank in Washington,D.C. “And we are not on a path currently to provide that.”
“That’s the conversation that we need to have,” Dempsey said, but not unilaterally, instead calling for countries in the region to face the reality of those needs. “It’s Beirut to Damascus to Baghdad,” Dempsey said.
From the outset of Syria’s civil war — despite its growth in to a multi-year conflict claiming more than 100,000 lives and dispersing millions into neighboring Middle East states — Dempsey and senior U.S. military leaders, including Gen. Ray Odierno, Army chief of staff and former commander of the Iraq war, in their efforts to prepare military options in Syria for President Barack Obama, have publicly questioned the purpose of American troops in Syria after an Assad defeat.
In Syria, government forces have regained control of Homs, the country’s third-largest city, where a 2-year siege has residents feeling like the war is over, according to the Los Angeles Times. Meanwhile, France alleged Syria has conducted more than one dozen chemical attacks since the United States opted against military strikes last fall, and Lakhdar Brahimi, the top United Nations negotiator on Syria resigned Tuesday, signaling the West’s frustration at getting Syria’s fighting factions toward any political solution and fears that much more conflict is likely to come.
“Look, if Assad took his family and all of his cronies and departed Syria today, how does that country ““ how does it articulate itself?” Dempsey said.
“I’ve heard it described as a succession of conflicts. You have the conflict that currently exists; then there’ll be the second conflict, which is kind of an internal conflict; and then there’ll be the third conflict against the terrorist organizations that are growing,” he said. “That’s probably right.”
What We're Following See More »
Senate Judiciary Committee Chairman Chuck Grassley (R-IA) said Monday he'd now be willing to hold a hearing on Supreme Court nominee Merrick Garland in a lame-duck session of Congress. While he said he wouldn't push for it, he said if "Hillary Clinton wins the White House, and a majority of senators convinced him to do so," he would soften his previous opposition.
In a new Monmouth University poll, 46% of likely voters support Clinton and 39% back Trump, with 7% supporting Libertarian Gary Johnson, and 2% backing Jill Stein of the Green Party. That's down from a poll taken right after the Democratic convention, in which Clinton led by 13 points.
“Hillary Clinton’s advisers are talking to Donald J. Trump’s ghostwriter of The Art of the Deal, seeking insights about Mr. Trump’s deepest insecurities as they devise strategies to needle and undermine him in four weeks at the first presidential debate, the most anticipated in a generation. ... Her team is also getting advice from psychology experts to help create a personality profile of Mr. Trump to gauge how he may respond to attacks and deal with a woman as his sole adversary on the debate stage.”
The House Committee on Oversight and Government Reform has requested documents from the CEO of Mylan, "the pharmaceutical company under fire after raising the price of EpiPens more than 400 percent since 2007." Meanwhile, top members of the Energy and Commerce Committee are pressing the FDA on the lack of generic competition for EpiPens.